Medicared For All Logo

Mark Harrison MD in Harlingen, Texas

Home Texas Harlingen

Mark Harrison MD has Radiation Oncology as his primary medical specialty. Their primary office is: 1719 Treasure Hills Blvd in Harlingen, Texas.

They're a part of the: Valley Cancer Associates Pa medical group which has around 3 members. You can call their office at 956-364-2131 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Cincinnati College Of Medicine and graduated in 1982 (around 42 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Mark L Harrison MD Office Phone and Directions

Mark Harrison MD
Valley Cancer Associates Pa
1719 Treasure Hills Blvd
Harlingen, Texas 78550
956-364-2131


Patient Ratings
Please rate your experience with Mark Harrison MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 956-364-2131


Enter a starting address:


Healthcare Info for Mark Harrison MD

Medical School: University Of Cincinnati College Of Medicine
Graduation Year: 1982
The Primary Medical Specialty for Mark Harrison MD is listed as: Radiation Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 42
PAC (PECOS ID)#: 2961305545
NPI #: 1417954124
NPI Created On: 07/07/2005
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 2085R0001X
License Number:
G4598
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Molina Marketplace
  • Celtic Insurance Company
  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.


Services and Procedures include:

  1. Ct scan chest
  2. Ct scan chest before and after contrast
  3. Ct scan abdomen before and after contrast
  4. Ct scan of abdomen and pelvis before and after contrast
  5. Ct scan guidance for insertion of radiation therapy fields
  6. Management of radiation therapy, complex
  7. Management of radiation therapy simulation, simple
  8. Management of radiation therapy, simulation, complex
  9. Calculation of radiation therapy dose
  10. Management of modulation radiotherapy planning
  11. Radiation treatment devices, design and construction, complex
  12. Radiation therapy consultation per week
  13. Design and construction of device for radiation therapy
  14. Radiation treatment management, 5 treatments
  15. Nuclear medicine study with ct imaging skull base to mid-thigh
  16. New patient office or other outpatient visit, typically 60 minutes
  17. Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
  18. Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev
  19. Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
  20. Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788217691

Being Disputed:: No

Product Related: No


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788217693

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788217697

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788217695

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788217699

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788217701

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818586375

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801987313

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832200591

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832200615

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Radiation Oncology Professionals in Harlingen

2121 Pease St
Harlingen, TX
Texas Oncology Pa

Providers in Valley Cancer Associates Pa

1.Mark Harrison Md

1719 Treasure Hills Blvd
Harlingen Tx 78550-8949
Valley Cancer Associates Pa
Radiation Oncology

2.Jose Maymi Md

844 Central Blvd
Brownsville Tx 78520-7552
Valley Cancer Associates Pa
Urology

3.Todd Shenkenberg

425 E Los Ebanos
Brownsville Tx 78520-8482
Valley Cancer Associates Pa
Medical Oncology

View all 3 members of Valley Cancer Associates Pa medical group